GENE ONLINE|News &
Opinion
Blog

In-Depth
Halting C.difficile with first-in-class oral enzyme & microbiome
2018-11-27
Precision Medicine & It’s Impact On Bioinnovation & Healthcare
2018-11-20
Treatment at a Cost – When Painkillers Could Double Cross
2018-11-19
A competition for cancer cells and human medical testing – How to use liquid biopsy to break through the testing dilemma?
2018-10-11
Targeting tumor heterogeneity with salvo of sequencing
2018-09-06
The Pharmacogenomics Landscape in Personalized Healthcare Space
2018-08-21
Biomarkers – Essentials of the Immunotherapy Toolbox
2018-07-24
The Amazing Era of the Second Brain
2018-07-14
PARP inhibitors in cancer – BRCA or no BRCA
2018-07-03
Oncolytic Virotherapy – An Overview
2018-06-27
1 8 9 10
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top